Table Of Content

Immunology and Cell Biology (1994) 72, 523-524 Author Index AdaG. 447 Dejehansart M. 415 Lam-Po-TangP.R.L. 440 Albrechtsen D. 455 Dorak M.T. 435 Layton J.E. 187 AltinJ.G. 87 Doran T.J. 427 LedbetterJ .A . 292 AndersonC.C. 508 Dubey M. L. 286 Lidbury B. A. 347 AndolzP. 1 Lindholm A. 455 East I. J. 333 Antoniou D. 230 LiuE. 275 Arellano A. 222 Eglinton B.A. 306 Liu W. 390 Armstrong D.T. 129 Ekberg H. 455 Lowenthal J.W. 115 AszalosA. 319 Elliott R. B. 390 Atkinson K. 49 Mahajan R.C. 286 Farrelly M. L. 161 Marquez C. 1 Bartlett L. 143 Martinez P. 1 Bartlett M.R.E. 367 Ganguly N.K. 286 Martorell R. 1 BaxterA.G. 137 Garcia-Framis V. 1 Mathur A. 200 BeaverJ.P. 489 Garnett H. M. 187 MatsuiS. 375 BeckR. 440 GarraudO. 169 MayumiM. 205 BenetJ. 1 Gatenby P. A. 7 McClive P.J . 137 BhatiaK. 23 Georgiou H.M. 57 McMullen G. L. 234 BiggsJ.C. 49 Gleeson P. A. 123 MMciWllaetre rsJP.F..AG..P. 131651 BirdC.H. 480 Gordon D.L. 222, 461 Bird P. 480 Greenway A.L. 234 MishraK. K. 419 Bonnemains B. 169 Mohan K. 286 Bourgeois C.S. 43 Halliday G.M. 383 Morahan G. 137 BourreauE. 169 HHaarrtmDo.nN .BJ..V . 1335 MoyanaT. 275 Bradstock K. F. 49 MuH-H. 267 BrienJ.H. 161 HataD. 205 Mukherjee B. 109 Britton W.J. 215 HayashiH. 249 Mukherjee J.R. 109 BrownJ.E. 69 Heike T. 205 Muller H. K. 79 Browne C.M. 177 Henniker A.J. 49 Murree-AllenK. 143 BrysonG.J. 35 Hernando R. A. 383 BuéinD. 455 Hertzog P.J. 234 Nukayal. 241 Higaki Y. 205 Burnett A. K. 435 BurtonR.C. 161 Hock B.D. 13 Ohshima Y. 205 ButtH. 143 Hodgson A. L.M. 427 Oka Y. 75 Hoftmann G. W. 338 OkadaN. 222 Callow M.G. 29 Holdsworth S$. R. 471 OliveC. 7 ChatterjeeM. 109 Holloway P.E. 79 Outteridge P.M. 256 Chaturvedi U.C. 200 Hook J. W. 326 OwhashiM. 249 CheersC. 314 Horiguchi Y. 205 Chouteau P. 169 HoussamiS. 314 PaglerE.B. 87 ClancyR.L. 143 HoyneG. F. 29 PaoliniR. 314 ClarkeG.R. 153 Hume D. A. 177 Papazaharoudakis H. 222 ColditzI.G. 398 HwangS.Y. 234 Parish C.R. 367 Collins R. J. 35 Parker S.J. 461 Connick T.E. 115 Ikemoto M. 375 Peake P. W. 215 Constantinou D. 57 Itoh T. 193 Pembrey R.G. 500 Cooley M. A. 267 PerrautR. 169 Cosntheeeion L.jJ. 471 KanazashiS. 205 Persson H. 455 CoverleyJ. 326 KarS.K. 419 Philcox J.C. 43 Cowden W.B. 367 Kawashimal. 193 PilarskiL.M. 292 Coyle P. 43 Kelso A. 97 Pine P. S. ° 319 CrippsA.W. 143 Keren D. F. 69 Cummins A.G. 230, 306 Keusch G. T. 69 QiY. 275 KhannaN. 200 QuintansJ. 262 Daish A. 13 Kim K-M. 205 DandieG. W. 79 Kinnear B. F. 87,500 Radford A. J. 427 Davenport M.P. 215 Kobayashi M. 375 RaftosD. A. 326 Davies J.K. 427 KooyJ. 123 Ragg S.J. 79 De BruynJ. 415 KovacsD.P.R. 129 RaisonR. L. 326 Deans J.P. 292 Kuo M-C. 29 RaoP.E. 319 524 Author Index Reddy S. 390 Srivastava A. K. 419 WardR.L. 49 Ribaudo C.M. 300 Suckow M. A. 69 Waring P. 489 Roberton D.M. 306 Sugiyama E. 375 Warren H.S. 87,367,500 Roberts T. K. 153 Sugiyama H. 75 WashingtonJ.M. 43 Roche P. W. 215 Suketa ¥. 241 Watkins F. Y. 79 Rofe A.M. 43 SuzukiH. 375 WeaverJ . L. 319 Roldan A. 300 Szabo G. Jr 319 Weisbart R. H. 513 Rondinone C.M. 300 Weston K.M. 326 RossI. L. 177 TakagiK. 241 White B.S. 23 Ruby J.C. 383 TaylorD.C. 143 WongA.L. 513 Teasdale M.S. 480 WoodP.R. 398 Sadlon T. A. 222, 461 Tekpetey F.R. 129 Woodroffe S. B. 187 Sakabe K. 193 Thomas W.R. 29 WorwoodM. 435 SantosL. 406 Thompson F.M. 230 Sasaki J-I. 415 Tipping P.G. 406, 471 Xiang J. 275 SchillaciR. 300 Toh B-H. 123 SeikiK. 193 TomiyoshiF. 249 Seow H-F. 398 Towns P. 326 YamaokaK. 205 SerjeantsonS. W. 7,23 TrentR.J. 23 Yamashita N. 375 Sewell W. A. 267 TsukadaS. 75 YasukawaK. 241 Shimizu Y. 75 TufvesonG. 455 YorJk.J . 115 Sinclair N. R. StC. 508 Tunrul.$. 375 YoshimuraT. 398 Skipsey L. J. 500 Smart Y.C. 153,161 UranoR. 193 Zack D. J. 513 SmithG. 49 Immunology and Cell Biology (1994) 72, 525-528 Subject Index Abelson virus mutants; used to transform immature B cell capsaicin; and mucosal mast cell activation 230 lines 75 carcinogen, chemical; and epithelial Langerhans’ cell Abstracts; Proceedings of the Australasian Society for migration 79 Experimental Pathology, 1994 A1 carcinoma cells, human colorectal; T cell killing of 275 activation antigen; characterization of 13 carrier molecules; tested in squirrel monkeys 169 adjuvant formulations; tested in squirrel monkeys 169 castanospermine; effects on allograft rejection and elicited AIDS pathogenesis; role of co-selection in peritoneal exudates 367 (Theoretical) 338 catalase; in streptozotocin-induced diabetic rats 109 allograft rejection; effects of anti-inflammatory compounds cation imbalance; in erythrocytes in malaria 286 on 367 CD16; molecular associations of, in natural killer cells 87 antibodies, antipeptide; to murine interferon-alpha 234 CD45 antibody binding sites; in lupus autoantibodies expression in natural killer lymphocytosis 500 (Theoretical) 513 and modulation of thymocyte proliferation 292 antibody production; regulation by nitrogen oxides 241 molecular associations of, in natural killer cells 87 antibody response; following antigenic immunization 169 CD59 upregulation; following cell activation 222 anti-DNA autoantibodies; in systemic lupus erythematosus cell activation; followed by upregulation of CD59 222 (Theoretical) 513 cell adhesion molecules; in Bae at a 471 antigen, leucocyte surface membrane; characterization cell cycle ot 49 effect of insulin-like growth factor-1on 300 anti-IgM antibody; growth inhibition of aB lymphoma cell flow cytometric study of 35 lineby 205 chemotactic activity, neutrophil; assay for 249 anti-inflammatory compounds; effect on allograft chronic obstructive lung disease; bronchitis in 143 rejection 367 complement anti-MHC class II antibodies; growth inhibition of aB activationof 461 lymphoma cell line by 205 regulationby CD59 222 antipeptide antibodies; to murine interferon-alpha 234 cord blood; comparison with adult blood (Brief antiviral cytokines; and evolution of viruses Comm.) 440 (Theoretical) 347 COS cells; thrombomodulin-transfected 480 apoptosis co-selection; in immune network theory and in AIDS and changes in intracellular calcium ion pathogenesis (Theoretical) 338 concentrations 489 cyclic expression; of B220 antigen in immature B cell a flow cytometric study of 35 lines 75 arthritis, adjuvant; attenuation by treatment with oxygen cyclophosphamide; suppression of immune response by 419 radical scavengers 406 cyclosporine; and renal graft survival 455 arthritis, rheumatoid; T cell oligoclonality in 7 cytokines autoantibodies antiviral, and evolution ofv iruses (Theoretical) 347 novel structural features of (Theoretical) 513 genes for, and viral infection 383 specific for the Golgicomplex 123 in human breast milk 306 autoantigens, Golgi; recognized by autoimmune sera 123 production of, inchicken 115 autoimmunity; and failed calibration of cells redundancy and specificity of ie 97 (Theoretical) 508 cytomegalovirus lbelions of vascular endothelial cells (Brief Comm.) 187 B cells; development of (Theoretical) 508 cytotoxic cells, natural; phenotype and morphology of 161 cytotoxic T cells; and MHC restriction (Review) 447 B-lymphoblast-lytic activity; of lymphokine-activated killer cells 375 decay accelerating factor; role in complement B lymphoma cell line; growth inhibition of 205 activation 461 bacterial colonization patterns; in bronchitis 143 beta-2 integrins; role in glomerular injury 471 decidua; and immunoregulation 153 diabetes; induced in ars. streptozotocin 109 blood, ae comparison with adult blood (Brief dimethylsulfoxide; in treatment of adjuvant arthritis 406 Comm.) 440 dimethylthiourea; in treatment of adjuvant arthritis 406 blood groups; Gerbich-negative 23 DNA content; in flow cytometry 35 breast milk, human; T cells and soluble immune factors in 306 egg, zona-free hamster; inhibition of penetration of 1 bronchitis, recurrent acute; prediction of 143 encephalitis, Japanese; vascular effects of 200 endocytosis; oft hrombomodulin 480 C3 deposition; on CD4 positive cells coated with endothelial cells; infected by cytomegalovirus (Brief recombinant gp120 461 Comm.) 187 calcium ion concentrations, intracellular; and apoptosis 489 eosinophilia; associated with vaccination against capillary permeability; in Japanese encephalitis 200 Oesophagostomum radiatum 333 526 Subject Index epidermal Langerhans’ cells; and intradermal infection with hydroxyl radical; role in mediation of joint inflammation in vaccinia virus constructs 383 arthritis 406 age cells, thymic; production and characterization oa 57 interferon-alpha; antipeptide antibodies to 234 epitopes, T cell; and mycobacterial infection 215 immune factors, soluble; in human breast milk 306 Eptatretus stouti; opsonic receptor on leucocytes from 326 immune network theory; co-selection in (Theoretical) 338 erythrocytes; and Plasmodium falciparum infection 286 immune response eukaryotic cells; and regulation of transcription development inchicken 115 (Theoretical) 177 recovery of, after cyclophosphamide 419 evolution; of unique immune evasion strategies by viruses immuni (Theoretical) 347 and 1» (Theoretical) 262 mucosal, to Shiga toxin in mice 69 immunization; of squirrel monkeys to test adjuvants and factor H; in complement activation 461 fertilization; inhibition of, by anti-sperm monoclonal carriers 169 immunodeficiency; and failed calibration of cells antibodies 1 (Theoretical) 508 flow cytome a could ofc eld eath using 35 immunoglobulin; joining region and variable region of natural cytotoxic cells 161 (Theoretical) 513 immunosuppression; by lymphokine-activated killer fluorescence energy transfer; on live cells 319 cells 375 fucoidan; effects on allograft rejection and elicited peritoneal inducible gene expression; in eukaryotic cells exudates 367 (Theoretical) 177 infections; and cytotoxic T cells (Review) 447 gamma chains; molecular associations of, in natural killer inflammation cells 87 and immunity (Theoretical) 262 gene expression regulation; in eukaryotic cells of joints in arthritis 406 (Theoretical) 177 inflammatory activity; of ovine interleukin-8 in skin 398 gene inactivation; of a cytokine or cytokine receptor insertion sequences, Mycobacteri um; putative functional (Theoretical) 97 domain within (Theoretical) 427 genetic variation; in non-obese diabetic mice 137 insulin-like growth factor-1; effect on lymphocyte Gerbich-negative blood group; in Papua New Guinea 23 proliferation 300 gliotoxin; and apoptosis inthymocytes 489 integrin, beta-2; role in glomerular injury 471 glomerulonephritis; and beta-2 integrins 471 interferon; and evolution of viruses (Theoretical) 347 glutathione levels; in streptozotocin-induced diabetic interleukin-2; and T cell killing of human colorectal rats 109 carcinoma cells 275 glutathione-reductase; in streptozotocin-induced diabetic interleukin-8, ovine; cloning, sequencing, expression and rats 109 inflammatory activity in kin of 398 glutathione-S-transferase; in streptozotocin-induced diabetic internalization; of thrombomodulin 480 rats 109 glycophorin C gene; and the Gerbich-negative blood Japanese encephalitis; vascular effects of 200 group Golgi complex; and anti-Golgi autoantibodies 123 L-selectin molecule; association with T cell receptor 319 gp120, recombinant; and complement activation 461 LAM1-1; association with T cell receptor 319 graft survival, renal; and HLA-A matching 455 Langerhans’ cells graft versus host disease; decreased severity after cord blood and intradermal infection with vaccinia virus transplantation (Brief Comm.) 440 constructs 383 granulocyte-CSF; and cytomegalovirus infection (Brief and migration into and out of - nodes 79 Comm.) 187 LECAM1; association with T cel receptor 319 granulocyte-macrophage-CSF; and cytomegalovirus Leu8; association with T cell receptor 319 infection (Brief Comm.) 187 leucocyte activation antigen; characterization of 13 growth inhibition; of a B lymphoma cell line 205 leucocyte surface membrane antigen; characterization of 49 leucocytes, peripheral blood; and response to mitogenic haemochromatosis; possible gene products of factors in seminal plasma 129 (Theoretical) 435 leukaemic leucocytes; a surface membrane antigen present Haemophilus influenzae, non-serotypable; in bronchitis 143 on 49 hagfish, Pacific; opsonic receptor on leucocytes from 326 lipid peroxidation; in streptozotocin-induced diabetic heat shock protein rats 109 mycobacterial, expression on Meth A tumour cells 415 lupus erythematosus, systemic; autoantibodies in and a Mycobacterium leprae-specific T cell epitope 215 (Theoretical) 513 HIV; and complement regulation 461 lymph nodes; and migration of Langherhans’ cells 79 HLA-A matching; and renal graft survival 455 lymphocyte differentiation antigens; in non-obese diabetic HLA-A3 antigen; and hereditary haemochromatosis mice 137 (Theoretical) 435 lymphocyte proliferation; effect of insulin-like growth factor- hormones, sex; effect on proliferation of thymic epithelial lon 300 cells 193 lymphocyte subsets; in cord blood compared to adult blood host-parasite relationship; in bronchitis 143 (BriefComm.) 440 Subject Index lymphocytes; calibration of (Theoretical) 508 opsonic receptor; on leucocytes from the Pacific lymphocytosis hagfish 326 . inducedb y pertussis toxin (Brief Comm.) 267 orogastric immunization in mice; with Shiga toxin 69 natural killer, and CD45RO expression 500 oxygen radical scavengers; in treatment of adjuvant lymphokine-activated killer cells; immunosuppression arthritis 406 by 375 pancreatic islets; targeted for passive transfer of spleen macrophage-derived neutrophil chemotactic factor; in cells 390 Japanese encephalitis 200 passive transfer; of spleen cells 390 major histocompatibility complex see MHC peptide vaccines; in domestic animals (Theoretical) 256 malaria; erythrocyte cation imbalance in 286 pertussis toxin; lymphocytosis induced by (Brief mannose-6-phosphate; effects on allograft rejection and Comm.) 267 elicited peritoneal exudates 367 phagocytic cells; and Pneumocystis carinii 314 maternal-fetal interface; and immunoregulation 153 Mamulienddienen and cation imbalance in membrane attack complex; regulation by CD59 222 erythrocytes 286 metabolism; of tumour-bearing rats on methotrexate 43 Pneumocystis carinii; measurement of microbicidal activity Meth A tumour cells; expression of mycobacterial heat shock against 314 proteinon 415 polymorphisms; in non-obese diabetic mice 137 methotrexate therapy; in tumour-bearing rats 43 eee leucocytes; expression of CD59 by 222 MHC; and peptide vaccines in domestic animals prednisolone; and renal graft survival 455 (Theoretical) 256 pregnancy, murine; andimmunoregulation 153 MHC restriction; history of research on (Review) 447 priming and tolerance, oral; epitopes in 29 microbicidal assay; for Pneumocystis carinii 314 protein C; activation of 480 microsatellites; in non-obese diabetic mice 137 protein kinase C; role in sex hormone induced cell milk, human breast; T cells and soluble immune factors proliferation 193 in 306 mitogenic factors; in porcine seminal plasma 129 receptors, cytokine; redundancy of (Theoretical) 97 monoclonal antibody recombinant gp120; and nine activation 461 CMRF-37 recognizes an activation antigen 13 regulation oftr anscription; in eukaryotic cells inhibition of fertilization by 1 (Theoretical) 177 WM65 recognizes a leucocyte surface membrane renal graft survival; and HLA-A matching 455 antigen 49 research on thymus; an overview (Burnet Oration) 361 mucosal immunity; to Shiga toxin in mice 69 rheumatoid arthritis; T cell oligoclonality in 7 mucosal mast cell; activation of 230 multinegative thymocyte proliferation; and modulation by self—non-self discrimination CD45 292 evolution of (Theoretical) 262 Mycobacterium bovis BCG stress protein; and Meth A tumour in lymphocytes (Theoretical) 508 cells 415 seminal plasma, porcine; response of peripheral blood Mycobacterium insertion sequences; putative functional leucocytes to mitogenic factors in 129 domain within (Theoretical) 427 severe combined immunodeficient mice; passive transfer of Mycobacterium leprae-specific T cell epitope; on 70 kDa heat non-obese diabetic mouse cells into 390 shock protein 215 sex steroid hormones; effect on proliferation of thymic epithelial cells 193 natural cytotoxic cells Shiga toxin; stimulation of gastrointestinal antibody to 69 at maternal-fetal interface 153 Shigella dysenteriae, orogastric immunization in mice phenotype and morphology of 161 with 69 natural killer cells Shigella dysenteriae antigens; immune response of BALB/c at maternal-fetal interface 153 mice to after <ganalabeniie 419 molecular associations of CD16, CD45 and zeta and Sjégren’s syndrome; anti-Golgi autoantibodies in patients gamma chains 87 with 123 natural killer lymphocytosis; and CD45RO expression 500 skin, sheep; and Langherhans’ cell migration 79 necrosis; a flow cytometric study of 35 sperm, human; monoclonal antibodies for 1 network theory, immune; co-selection in (Theoretical) 338 spleen; and natural cytotoxic activity 161 neutrophil chemotactic factor; isolated from Tritrichomonas spleen cells; passive transfer of 390 foetus 249 squirrel monkeys; as models for evaluating vaccine neutrophil recruitment; in glomerulonephritis 471 candidates 169 nitric oxide; regulation of antibody ceutlialian by 241 steroids, sex; effect on proliferation of thymic epithelial nitrogen oxides; regulation of antibody production by 241 cells 193 non-obese diabetic mice stochastic gene expression; in eukaryotic cells genetic polymorphisms of 137 (Theoretical) 177 passive transfer of allogeneic spleen cells from 390 streptozotocin; used to induce diabetes in rats 109 thymic epithelial cell lines derived from 57 substance P; depletion of by capsaicin 230 superantigen binding site; and lupus autoantibodies Oesophagostomum radiatum; vaccination against 333 (Theoretical) 513 oligoclonality; of T cells in peripheral blood in rheumatoid surface membrane antigen, leucocyte; characterization arthritis 7 of 49 528 Subject Index systemic lupus erythematosus; autoantibodies in transferrin receptor; and thymus-leukaemia antigens (Theoretical) 513 (Theoretical) 435 transformation; of immature B cell lines with temperature- T cell epitope, Mycobacterium leprae-specific; identified on 70 sensitive mutant virus 75 kDa ae shock protein 215 Tritrichomonas foetus; isolation of a neutrophil chemotactic T cell oligoclonality, gamma/delta; in peripheral blood in factor from 249 rheumatoid arthritis 7 tumour cells T cell receptor Meth A, expression of mycobacterial heat shock protein association of L-selectin molecule with 319 on 415 and MHC restriction (Review) 447 T cell killing of 275 T cells tumour necrosis factor; and evolution of viruses development of (Theoretical) 508 (Theoretical) 347 epitopes of, during oral tolerance and priming 29 tumour-bearing rats; methotrexate therapy in 43 in human breast milk 306 immune responsiveness, development in chicken 115 vaccination and intradermal infection with vaccinia virus against Oesophagostomum radiatum 333 constructs 383 Barwon animals (Theoretical) 256 and killing of tumour cells 275 and testing of adjuvants and carriers in squirrel temperature-sensitive mutants; of Abelson virus 75 monkeys 169 thapsigargin; and apoptosis in thymocytes 489 vaccinia virus constructs; effects of intradermal infection thrombomodiulin; internalization of 480 with 383 thymic epithelial cell proliferation; effect of sex steroids vascular endothelial cells; infected by cytomegalovirus (Brief on 193 Comm.) 187 thymocyte proliferation; and modulation by CD45 292 vascular cersenemane in Japanese encephalitis 200 thymus viruses; evolution of unique immune evasion strategies by mouse neonatal, epithelial cell lines derived from 57 (Theoretical) 347 overview of research on (Burnet Oration) 361 thymus-leukaemia antigens; may be the haemochromatosis gene product (Theoretical) 435 weaning; and mucosal mast cell activation 230 tolerance and priming, oral; epitopes in 29 transcription regulation; in a cells zeta chains; molecular associations of, in natural killer (Theoretical) 177 cells 87 transfer, passive; of spleen cells 390 zona-free hamster egg; inhibition of penetration of 1